Nick Keher Acquires 15,325 Shares of Oxford Nanopore Technologies (LON:ONT) Stock

Key Points

• Insider buying: Nick Keher purchased 15,325 Oxford Nanopore Technologies shares at GBX 162 each, for a total of £24,826.50. He also made smaller purchases in June, July and August.
• Stock performance and financials: Shares opened at GBX 166.08, with a 52-week range of GBX 95.61 to GBX 191.40 and a market capitalization of £1.62 billion. The company reported a quarterly loss of GBX 4.90 per share and negative profitability metrics.
• Analyst outlook: Analysts maintain a generally positive view, with five Buy ratings and one Hold rating. The consensus rating is “Moderate Buy,” with an average price target of GBX 198.60.

Oxford Nanopore Technologies plc (LON:ONT - Get Free Report) insider Nick Keher purchased 15,325 shares of the business's stock in a transaction that occurred on Friday, September 4th. The stock was bought at an average price of GBX 162 per share, with a total value of £24,826.50.

Nick Keher also recently made the following trade(s):

• On Wednesday, August 12th, Nick Keher purchased 115 shares of Oxford Nanopore Technologies stock. The shares were bought at an average cost of GBX 131 per share, for a total transaction of £150.65.
• On Tuesday, July 14th, Nick Keher acquired 123 shares of Oxford Nanopore Technologies stock. The shares were bought at an average price of GBX 121 per share, for a total transaction of £148.83.
• On Friday, June 12th, Nick Keher acquired 121 shares of Oxford Nanopore Technologies stock. The stock was bought at an average cost of GBX 124 per share, with a total value of £150.04.

Oxford Nanopore Technologies Stock Performance

LON:ONT opened at GBX 166.08 on Friday. The stock has a fifty day moving average price of GBX 130.52 and a 200-day moving average price of GBX 124.60. The company has a market cap of £1.62 billion, a price-to-earnings ratio of -11.00 and a beta of 0.91. The company has a debt-to-equity ratio of 9.86, a quick ratio of 6.01 and a current ratio of 3.52. Oxford Nanopore Technologies plc has a fifty-two week low of GBX 95.61 and a fifty-two week high of GBX 191.40.

Oxford Nanopore Technologies (LON:ONT - Get Free Report) last released its earnings results on Wednesday, August 19th. The company reported GBX (4.90) earnings per share (EPS) for the quarter. Oxford Nanopore Technologies had a negative return on equity of 35.45% and a negative net margin of 54.66%.

Analysts Set New Price Targets

Several equities analysts have commented on the stock. JPMorgan Chase & Co. raised their target price on shares of Oxford Nanopore Technologies from GBX 190 to GBX 220 and gave the company an "overweight" rating in a report on Thursday, August 27th. Royal Bank Of Canada reiterated an "outperform" rating and set a GBX 225 price target on shares of Oxford Nanopore Technologies in a research report on Tuesday, May 26th. Deutsche Bank Aktiengesellschaft reissued a "buy" rating and issued a GBX 195 price objective on shares of Oxford Nanopore Technologies in a research note on Thursday, August 20th. Berenberg Bank lowered their price objective on shares of Oxford Nanopore Technologies from GBX 220 to GBX 200 and set a "buy" rating for the company in a research report on Wednesday, August 19th. Finally, Peel Hunt restated a "hold" rating and set a GBX 153 target price on shares of Oxford Nanopore Technologies in a research note on Monday, July 13th. Five analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of GBX 198.60.

About Oxford Nanopore Technologies

Oxford Nanopore Technologies' goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The Group has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 125 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source